+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

India Stem Cell Market by Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), by Application (Regenerative Medicine Vs. Drug Discovery & Development), by Technology, by Region, Competition Forecast & Opportunities, FY 2026

  • ID: 5174096
  • Report
  • October 2020
  • Region: India
  • 78 pages
  • TechSci Research

Enquire about COVID-19 updates for this product.

Enquire Now
The Indian Stem Cell Market is Expected to Grow at Over 12% CAGR During FY 2021 - FY 2026.

FEATURED COMPANIES

  • Cordlife India
  • ReeLabs Private Limited
  • Reliance Life Sciences
  • MORE
The Indian Stem Cell Market is expected to grow at over 12% CAGR during FY 2021 - FY 2026. Continuous advancements in tissue engineering is one of the prime factors boosting the Indian Stem Cell Market. Development of regenerative medicines coupled with growing cases of chronic and genetic diseases across the country are some of the other factors anticipated to drive the growth of the stem cell market during the forecast years. Moreover, availability of funds from the government and certain organizations is estimated to bode well for the growth of the Indian Stem Cell Market over the next five years.

The Indian Stem Cell Market is segmented based on product type, application, technology, and region. Based on product type, the market can be categorized into adult, induced pluripotent, human embryonic and others. Out of these, the adult stem cells segment dominated the market until FY 2020 and is further expected to maintain its leading position in the market during the forecast period as well on account of reduced contamination risk associated with sub-culturing. Moreover, its compatibility with the human body is expected to drive the segment growth over the coming years. Additionally, less requirement for production labor is boosting the growth of adult stem cells segment.

Major players operating in the Indian Stem Cell Market include Reliance Life Sciences, LifeCell International Private Limited, Cryobanks International India Private Limited, Cordlife India, StemCyte India Therapeutics Private Limited, ReeLabs Private Limited, Stempeutics Research Private Limited, among others. The companies are focussing on extensive research and developments activities in order to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.

Years considered for this report:
  • Historical Years: FY 2016 - FY 2019
  • Base Year: FY 2020
  • Estimated Year: FY 2021
  • Forecast Period: FY 2022 - FY 2026
Objective of the Study:
  • To analyze and forecast the market size of the Indian Stem Cell Market.
  • To classify and forecast the Indian Stem Cell Market based on product type, application, technology, and regional distribution.
  • To identify drivers and challenges for the Indian Stem Cell Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Indian Stem Cell Market.
  • To identify and analyze the profile of leading players operating in the Indian Stem Cell Market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies which could not be identified due to the limitations of secondary research. The publisher analyzed the companies, distribution channels and presence of all major players across the country.

The publisher calculated the market size of the Indian Stem Cell Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Stem cell companies, medical research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to stem cell
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:

In this report, the Indian Stem Cell Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Product Type:
  • Adult
  • Induced Pluripotent
  • Human Embryonic
  • Others
Market, By Application:
  • Regenerative Medicine
  • Drug Discovery & Development
Market, By Technology:
  • Cell Acquisition
  • Cell Production
  • Cryopreservation
  • Expansion & Subculture
Market, By Region:
  • North
  • East
  • West
  • South
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Indian Stem Cell Market.

Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cordlife India
  • ReeLabs Private Limited
  • Reliance Life Sciences
  • MORE
1. Product of Interest Introduction: Stem Cell

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. India Stem Cell Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others)
5.2.2. By Application (Regenerative Medicine Vs. Drug Discovery & Development)
5.2.3. By Technology (Cell Acquisition; Cell Production; Cryopreservation; Expansion & Subculture)
5.2.4. By Region (North, South, East, West)
5.2.5. By Company
5.3. Market Attractiveness Index

6. India Stem Cell Acquisition Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)
6.2.2. By Type (Bone Marrow Harvest; Umbilical Blood Cord; and Apheresis)

7. India Stem Cell Production Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)
7.2.2. By Type (Therapeutic cloning; In vitro fertilization; Cell culture; and Isolation)

8. India Stem Cell Cryopreservation Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)

9. India Stem Cell Expansion & Sub-culture Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)

10. Supply Chain Analysis

11. Import & Export Analysis

12. Market Dynamics
12.1. Drivers/Opportunities
12.2. Challenges/Restraints

13. Market Trends & Developments

14. Policy & Regulatory Landscape

15. India Economic Profile

16. Competitive Landscape
16.1. Company Profiles
16.1.1. Reliance Life Sciences
16.1.2. LifeCell International Private Limited
16.1.3. Cryobanks International India Private Limited
16.1.4. Cordlife India
16.1.5. StemCyte India Therapeutics Private Limited
16.1.6. ReeLabs Private Limited
16.1.7. Stempeutics Research Private Limited

17. Strategic Recommendations

List of Figures
Figure 1: India Stem Cell Market Size, By Value (USD Million), FY 2016 - FY 2026F
Figure 2: India Stem Cell Market Share, By Product Type, FY 2016 - FY 2026F
Figure 3: India Stem Cell Market Size, By Cell Acquisition, FY 2016 - FY 2026F
Figure 4: India Stem Cell Market Size, By Cell Production, FY 2016 - FY 2026F
Figure 5: India Stem Cell Market Size, By Cryopreservation, FY 2016 - FY 2026F
Figure 6: India Stem Cell Market Size, By Expansion & Subculture, FY 2016 - FY 2026F
Figure 7: India Stem Cell Market Share, By Technology, FY 2016 - FY 2026F
Figure 8: India Stem Cell Market Share, By Application, FY 2016 - FY 2026F
Figure 9: India Stem Cell Market Share, By End-User, FY 2016 - FY 2026F
Figure 10: India Stem Cell Market Share, By Company, FY 2016 - FY 2026F
Figure 11: India Stem Cell Market Share, By Region, FY 2016 - FY 2026F
Figure 12: India Stem Cell Market Share Attractiveness Index, By Type, By Value, FY 2016 - FY 2026F
Note: Product cover images may vary from those shown
  • Reliance Life Sciences
  • LifeCell International Private Limited
  • Cryobanks International India Private Limited
  • Cordlife India
  • StemCyte India Therapeutics Private Limited
  • ReeLabs Private Limited
  • Stempeutics Research Private Limited
Note: Product cover images may vary from those shown
Adroll
adroll